diphtheria, tetanus, pertussis (acellular), hib vaccine and poliomyelitis · Medicine question

Why is evaluation of pharmacokinetic properties not required for Infanrix-IPV+Hib?

Name: Why is evaluation of pharmacokinetic properties not required for Infanrix-IPV+Hib?
Published: 2026-11-08T13:45:34.005Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Evaluation of pharmacokinetic properties is not required for Infanrix-IPV+Hib because it is a vaccine, and such evaluation is not required for vaccines.

Sources for this answer

Infanrix-IPV+Hib, powder and suspension for suspension for injectionGlaxoSmithKline UK · emc · SmPC §5.2 Pharmacokinetic properties · Version 10Document updated 11 November 2024

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about diphtheria, tetanus, pertussis (acellular), hib vaccine and poliomyelitis